Our physician office business for medical and laboratory products is now part of Henry Schein Medical — the world’s largest provider of health care products and services for office-based medical, dental, and animal health practitioners.
We offer a range of cost-efficient, clinician-preference items with low clinical differentiation.
We deliver the essential pharmaceuticals that care providers need to keep their patients healthy.
We give providers access to products and help manufacturers bring products to market effectively.
Looking ahead with the leading minds in healthcare.
Read expert commentary, best practices, and insights from the leaders who are shaping the industry.
Find articles that are relevant to your field of interest.
Learn more about how Cardinal Health is improving healthcare through our company history and facts, our diverse supplier base and business conduct standards, and our recent awards and innovation lab.
It has been a decades-long battle to reach fair reimbursement regulations for Medicaid programs and pharmacies. As of February 1, 2016, the long awaited final AMP rule was released by the Centers for Medicare and Medicaid Services (CMS) and was published in the Federal Register to showcase the impact on pharmacy reimbursement.
The final rule is designed to ensure that pharmacy reimbursement aligns with the acquisition cost of drugs, and that states pay a suitable professional dispensing fee. The rule recognizes that Congress allows individual multi-source generic drugs to be paid above the AMP times 175% target. Bear in mind that the 658-page policy is still in early stages of assessment, but there are several provisions that highlight the fair treatment of community pharmacies, allowing them to continue to provide patient access to their services.
Below are a few key points outlined by the new rule:
©2016 Cardinal Health. All rights reserved.